Upload Image (Max 20MB per Image)
Astellas Pharma and Drais Pharmaceuticals have partnered to develop and commercialize a melanocortin receptor agonist for the potential treatment of ulcerative colitis through Telsar Pharma. Under the agreement, Astellas will transfer all ...
Tags: Astellas Pharma, melanocortin receptor, ASP3291